vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Orange County Bancorp, Inc. (OBT). Click either name above to swap in a different company.
Orange County Bancorp, Inc. is the larger business by last-quarter revenue ($33.0M vs $31.1M, roughly 1.1× LIFECORE BIOMEDICAL, INC. \DE\). Orange County Bancorp, Inc. runs the higher net margin — 37.6% vs -32.1%, a 69.7% gap on every dollar of revenue. On growth, Orange County Bancorp, Inc. posted the faster year-over-year revenue change (20.6% vs -4.5%). Orange County Bancorp, Inc. produced more free cash flow last quarter ($41.3M vs $25.0K). Over the past eight quarters, Orange County Bancorp, Inc.'s revenue compounded faster (14.3% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.
LFCR vs OBT — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $33.0M |
| Net Profit | $-10.0M | $12.4M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | 41.4% |
| Net Margin | -32.1% | 37.6% |
| Revenue YoY | -4.5% | 20.6% |
| Net Profit YoY | -52.0% | 73.5% |
| EPS (diluted) | $-0.29 | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $33.0M | ||
| Q3 25 | $31.1M | $33.7M | ||
| Q2 25 | — | $32.5M | ||
| Q1 25 | $35.2M | $28.0M | ||
| Q4 24 | $32.6M | $27.4M | ||
| Q3 24 | $24.7M | $27.1M | ||
| Q2 24 | — | $27.9M | ||
| Q1 24 | $35.7M | $25.3M |
| Q4 25 | — | $12.4M | ||
| Q3 25 | $-10.0M | $10.0M | ||
| Q2 25 | — | $10.5M | ||
| Q1 25 | $-14.8M | $8.7M | ||
| Q4 24 | $-6.6M | $7.2M | ||
| Q3 24 | $-16.2M | $3.2M | ||
| Q2 24 | — | $8.2M | ||
| Q1 24 | $15.6M | $9.3M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | 41.4% | ||
| Q3 25 | -9.9% | 38.6% | ||
| Q2 25 | — | 41.9% | ||
| Q1 25 | -25.7% | 40.3% | ||
| Q4 24 | -6.0% | 32.8% | ||
| Q3 24 | -46.9% | 14.8% | ||
| Q2 24 | — | 36.6% | ||
| Q1 24 | -2.5% | 45.9% |
| Q4 25 | — | 37.6% | ||
| Q3 25 | -32.1% | 29.7% | ||
| Q2 25 | — | 32.2% | ||
| Q1 25 | -42.0% | 31.1% | ||
| Q4 24 | -20.2% | 26.2% | ||
| Q3 24 | -65.7% | 11.8% | ||
| Q2 24 | — | 29.4% | ||
| Q1 24 | 43.8% | 36.7% |
| Q4 25 | — | $0.94 | ||
| Q3 25 | $-0.29 | $0.75 | ||
| Q2 25 | — | $0.87 | ||
| Q1 25 | $-0.47 | $0.77 | ||
| Q4 24 | $-0.25 | $0.64 | ||
| Q3 24 | $-0.53 | $0.28 | ||
| Q2 24 | — | $0.73 | ||
| Q1 24 | $0.42 | $0.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | — |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $284.4M |
| Total Assets | $235.2M | $2.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $18.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $9.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $284.4M | ||
| Q3 25 | $-10.5M | $270.1M | ||
| Q2 25 | — | $252.6M | ||
| Q1 25 | $2.2M | $201.3M | ||
| Q4 24 | $15.4M | $185.5M | ||
| Q3 24 | $-3.9M | $193.1M | ||
| Q2 24 | — | $177.5M | ||
| Q1 24 | $17.7M | $168.7M |
| Q4 25 | — | $2.7B | ||
| Q3 25 | $235.2M | $2.6B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | $237.7M | $2.6B | ||
| Q4 24 | $255.4M | $2.5B | ||
| Q3 24 | $246.8M | $2.5B | ||
| Q2 24 | — | $2.5B | ||
| Q1 24 | $246.2M | $2.5B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $43.8M |
| Free Cash FlowOCF − Capex | $25.0K | $41.3M |
| FCF MarginFCF / Revenue | 0.1% | 125.1% |
| Capex IntensityCapex / Revenue | 5.6% | 7.6% |
| Cash ConversionOCF / Net Profit | — | 3.53× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $69.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $43.8M | ||
| Q3 25 | $1.8M | $30.2M | ||
| Q2 25 | — | $-5.0M | ||
| Q1 25 | $1.2M | $4.8M | ||
| Q4 24 | $-6.1M | $34.6M | ||
| Q3 24 | $-613.0K | $10.2M | ||
| Q2 24 | — | $9.3M | ||
| Q1 24 | $-1.4M | $2.3M |
| Q4 25 | — | $41.3M | ||
| Q3 25 | $25.0K | $29.6M | ||
| Q2 25 | — | $-5.7M | ||
| Q1 25 | $-4.3M | $4.3M | ||
| Q4 24 | $-8.6M | $32.9M | ||
| Q3 24 | $-4.0M | $10.0M | ||
| Q2 24 | — | $9.2M | ||
| Q1 24 | $-7.8M | $2.0M |
| Q4 25 | — | 125.1% | ||
| Q3 25 | 0.1% | 87.8% | ||
| Q2 25 | — | -17.5% | ||
| Q1 25 | -12.1% | 15.5% | ||
| Q4 24 | -26.3% | 120.0% | ||
| Q3 24 | -16.3% | 36.7% | ||
| Q2 24 | — | 32.8% | ||
| Q1 24 | -21.8% | 7.9% |
| Q4 25 | — | 7.6% | ||
| Q3 25 | 5.6% | 1.8% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | 15.5% | 1.8% | ||
| Q4 24 | 7.5% | 6.3% | ||
| Q3 24 | 13.9% | 1.1% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | 17.8% | 1.0% |
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | — | -0.47× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | — | 4.83× | ||
| Q3 24 | — | 3.19× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | -0.09× | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
OBT
Segment breakdown not available.
